Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size by Application

  2.3.2 Market Size by Delivery Method

  2.3.3 Market Size by End User     

 2.4 Market Share & Bps Analysis by Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

3.4.1 Raw Material, Reagent & Delivery System Suppliers

3.4.2 mRNA Technology Developers & Manufacturers

3.4.3 Contract Development, Manufacturing & Research Service Providers

3.4.4 Pharmaceutical Companies, Research Institutes & End Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Clinical Development & Pipeline Trends (2025)

4.1.1 Number of mRNA Candidates in Clinical Development

4.1.2 Clinical Trial Distribution by Therapeutic Area

4.1.3 Phase I, II & III mRNA Pipeline Trends

4.1.4 Growth in Personalized mRNA Therapy Programs

4.2 Infectious Disease & Vaccine Adoption Trends (2025)

4.2.1 Global mRNA Vaccine Administration Trends

4.2.2 Expansion of mRNA Vaccines Beyond COVID-19

4.2.3 RSV, Influenza & Combination Vaccine Development Activity

4.2.4 Government Procurement & Immunization Program Trends

4.3 Oncology & Therapeutic Application Trends (2025)

4.3.1 Growth in mRNA-Based Cancer Immunotherapy Programs

4.3.2 Personalized Neoantigen Vaccine Development Trends

4.3.3 Rare Disease & Genetic Disorder Research Activity

4.3.4 Autoimmune & Chronic Disease mRNA Application Trends

4.4 Manufacturing Capacity & Investment Trends (2025)

4.4.1 Global mRNA Manufacturing Capacity Expansion

4.4.2 Investments in mRNA Production Facilities

4.4.3 Lipid Nanoparticle (LNP) Production Capacity Trends

4.4.4 Public & Private Funding for mRNA Technology Development

4.5 Research, Innovation & Regulatory Trends (2025)

4.5.1 Patent Filings Related to mRNA Technologies

4.5.2 Advances in Delivery Systems & LNP Technologies

4.5.3 Regulatory Approvals & Fast-Track Designations

4.5.4 Strategic Collaborations, Licensing & Partnership Activity

5. MRNA Technology Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Infectious Diseases

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

5.3 Cancer Immunotherapy

5.4 Rare Genetic Disorders

5.5 Cardiovascular Diseases

5.6 Others

6. MRNA Technology Market Segmental Analysis & Forecast, By Delivery Method, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Lipid Nanoparticles

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

6.3 Polymeric Carriers

6.4 Electroporation

6.5 Others

7. MRNA Technology Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

     7.1 Introduction

 7.2 Pharmaceutical & Biotechnology Companies

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

7.3 Research Institutes & Academic Centres

7.4 Contract Research Organisations (CROs)

7.5 Others

8. MRNA Technology Market Segmental Analysis & Forecast, By Region, 2022 – 2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 MRNA Technology Market Size & Forecast, By Application, 2022–2035

 8.2.3 MRNA Technology Market Size & Forecast, By Delivery Method, 2022–2035

 8.2.4 MRNA Technology Market Size & Forecast, By End User, 2022–2035

 8.2.5 MRNA Technology Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 MRNA Technology Market Size & Forecast, By Application, 2022–2035

 8.3.3 MRNA Technology Market Size & Forecast, By Delivery Method, 2022–2035

 8.3.4 MRNA Technology Market Size & Forecast, By End User, 2022–2035

 8.3.5 MRNA Technology Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 MRNA Technology Market Size & Forecast, By Application, 2022–2035

 8.4.3 MRNA Technology Market Size & Forecast, By Delivery Method, 2022–2035

 8.4.4 MRNA Technology Market Size & Forecast, By End User, 2022–2035

 8.4.5 MRNA Technology Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 MRNA Technology Market Size & Forecast, By Application, 2022–2035

 8.5.3 MRNA Technology Market Size & Forecast, By Delivery Method, 2022–2035

 8.5.4 MRNA Technology Market Size & Forecast, By End User, 2022–2035

 8.5.5 MRNA Technology Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 MRNA Technology Market Size & Forecast, By Application 2022–2035

 8.6.3 MRNA Technology Market Size & Forecast, By Delivery Method, 2022–2035

 8.6.4 MRNA Technology Market Size & Forecast, By End User, 2022–2035

 8.6.5 MRNA Technology Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 Egypt

  8.6.5.5 South Africa

  8.6.5.6 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022 – 2035

  9.2.3 Number of Strategies Adopted by Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features by Key Players

  9.4.2 Product/Service Heatmap by Key Players

  9.4.3 Application Heatmap by Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

9.6.1 Moderna

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Product/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

9.6.2 Pfizer

9.6.3 BioNTech

9.6.4 AstraZeneca

9.6.5 CureVac

9.6.6 Arcturus Therapeutics

9.6.7 Translate Bio

9.6.8 Sanofi

9.6.9 Merck & Co.

9.6.10 Alnylam Pharmaceuticals

9.6.11 Beam Therapeutics

9.6.12 Precision BioSciences

9.6.13 Ethris GmbH

9.6.14 eTheRNA Immunotherapies

9.6.15 Entos Pharmaceuticals

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions on Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List of Tables

 13.2 List of Figures